Dermatomyositis is not a condition that reveals itself in a straightforward way. It can begin quietly — unusual muscle weakness climbing stairs, a purplish rash on the eyelids or knuckles, fatigue that feels disproportionate to effort.

Living with polymyositis means living with a condition that most people have never heard of — and that even many clinicians see rarely. The progressive proximal muscle weakness, the fatigue that goes far beyond tiredness, the uncertainty about flares: these experiences are real and specific, and they deserve more than a generic framework built around suppressing symptoms and waiting to see what…

Juvenile dermatomyositis is one of the rarest and most biologically complex autoimmune conditions affecting children. If your child has been diagnosed — or if you spent months trying to get a diagnosis confirmed — you already know how disorienting this experience can be.

Limb-girdle muscular dystrophy is not a single disease. It is a family of more than 30 genetically distinct conditions that share one outcome: progressive weakness of the shoulder and hip muscles that, over years or decades, erodes independence.

Facioscapulohumeral muscular dystrophy (FSHD) is not a simple genetic disease. Unlike conditions where a gene is broken or missing, FSHD is caused by a gene that should be permanently silent — waking up in tissue where it has no business being active.

If you have been on corticosteroids for more than a few weeks and your legs feel heavier climbing stairs, or standing up from a chair takes real effort, you have probably already heard the standard advice: "take vitamin D, do some light exercise, and mention it at your next appointment." That advice is not wrong.